Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
OLANZAPINE SANDOZ olanzapine 2. 5mg film coated tablet, blister pack, Sandoz Pty Ltd, CON-966
Product name
OLANZAPINE SANDOZ olanzapine 2. 5mg film coated tablet, blister pack
Sponsor name
Sandoz Pty Ltd
Batches
MB8452
Consent start
Consent no.
CON-966
Standard
Paragraphs 10(14)(a)(vii) and (viii) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The affected batch (as listed in the TGA consent letter of 12 july 2022) of
product blister pack does not include the relevant batch and expiry prefixes.
Conditions imposed
A 'Dear Healthcare Provider' letter identical to that provided to the
Therapeutic Goods Administration on 29 June 2022 will be supplied with each
affected batch
Therapeutic product type
Prescription medicines